These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 26296371)

  • 41. Ablation of colorectal liver metastases by irreversible electroporation: results of the COLDFIRE-I ablate-and-resect study.
    Scheffer HJ; Nielsen K; van Tilborg AA; Vieveen JM; Bouwman RA; Kazemier G; Niessen HW; Meijer S; van Kuijk C; van den Tol MP; Meijerink MR
    Eur Radiol; 2014 Oct; 24(10):2467-75. PubMed ID: 24939670
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A prospective Phase 2a pilot study investigating focal percutaneous irreversible electroporation (IRE) ablation by NanoKnife in patients with localised renal cell carcinoma (RCC) with delayed interval tumour resection (IRENE trial).
    Wendler JJ; Porsch M; Nitschke S; Köllermann J; Siedentopf S; Pech M; Fischbach F; Ricke J; Schostak M; Liehr UB
    Contemp Clin Trials; 2015 Jul; 43():10-9. PubMed ID: 25962890
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Electrical and thermal analyses of catheter-based irreversible electroporation of digestive tract.
    Ren F; Li Q; Gao X; Zhu K; Zhang J; Chen X; Yan X; Chu D; Hu L; Gao Z; Wu Z; Wu R; Lv Y
    Int J Hyperthermia; 2019; 36(1):854-867. PubMed ID: 31452435
    [No Abstract]   [Full Text] [Related]  

  • 44. Investigation of safety for electrochemotherapy and irreversible electroporation ablation therapies in patients with cardiac pacemakers.
    Jarm T; Krmac T; Magjarevic R; Kos B; Cindric H; Miklavcic D
    Biomed Eng Online; 2020 Nov; 19(1):85. PubMed ID: 33198769
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pair-matched patient-reported quality of life and early oncological control following focal irreversible electroporation versus robot-assisted radical prostatectomy.
    Scheltema MJ; Chang JI; Böhm M; van den Bos W; Blazevski A; Gielchinsky I; Kalsbeek AMF; van Leeuwen PJ; Nguyen TV; de Reijke TM; Siriwardana AR; Thompson JE; de la Rosette JJ; Stricker PD
    World J Urol; 2018 Sep; 36(9):1383-1389. PubMed ID: 29594551
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Irreversible electroporation of the porcine kidney: Temperature development and distribution.
    Wagstaff PG; de Bruin DM; van den Bos W; Ingels A; van Gemert MJ; Zondervan PJ; Verdaasdonk RM; van Lienden KP; van Leeuwen TG; de la Rosette JJ; Laguna Pes MP
    Urol Oncol; 2015 Apr; 33(4):168.e1-7. PubMed ID: 25557146
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Why we should not routinely apply irreversible electroporation as an alternative curative treatment modality for localized prostate cancer at this stage.
    Wendler JJ; Ganzer R; Hadaschik B; Blana A; Henkel T; Köhrmann KU; Machtens S; Roosen A; Salomon G; Sentker L; Witzsch U; Schlemmer HP; Baumunk D; Köllermann J; Schostak M; Liehr UB
    World J Urol; 2017 Jan; 35(1):11-20. PubMed ID: 27147512
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prostate cancer treatment with Irreversible Electroporation (IRE): Safety, efficacy and clinical experience in 471 treatments.
    Guenther E; Klein N; Zapf S; Weil S; Schlosser C; Rubinsky B; Stehling MK
    PLoS One; 2019; 14(4):e0215093. PubMed ID: 30986263
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel Ablation Therapy Using Endoscopic Irreversible Electroporation in the Bile Duct: A Pilot Animal Study.
    Lee KW; Lee JM; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Um SH; Lee HS; Chun HJ; Kim CD; Oh CH; Kim HB
    Clin Endosc; 2021 May; 54(3):413-419. PubMed ID: 33076633
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Outcomes of salvage radical prostatectomy after initial irreversible electroporation treatment for recurrent prostate cancer.
    van Riel LAMJG; Geboers B; Kabaktepe E; Blazevski A; Reesink DJ; Stijns P; Stricker PD; Casanova J; Dominguez-Escrig JL; de Reijke TM; Scheltema MJ; Oddens JR
    BJU Int; 2022 Nov; 130(5):611-618. PubMed ID: 35474600
    [TBL] [Abstract][Full Text] [Related]  

  • 51. A multi-center international study to evaluate the safety, functional and oncological outcomes of irreversible electroporation for the ablation of prostate cancer.
    Zhang K; Stricker P; Löhr M; Stehling M; Suberville M; Cussenot O; Lunelli L; Ng CF; Teoh J; Laguna P; de la Rosette J
    Prostate Cancer Prostatic Dis; 2024 Sep; 27(3):525-530. PubMed ID: 38195916
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A Conceivable Mechanism Responsible for the Synergy of High and Low Voltage Irreversible Electroporation Pulses.
    Lv Y; Yao C; Rubinsky B
    Ann Biomed Eng; 2019 Jul; 47(7):1552-1563. PubMed ID: 30953220
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Contrast Enhancement Patterns after Irreversible Electroporation: Experimental Study of CT Perfusion Correlated to Histopathology in Normal Porcine Liver.
    Chung DJ; Sung K; Osuagwu FC; Wu HH; Lassman C; Lu DS
    J Vasc Interv Radiol; 2016 Jan; 27(1):104-11. PubMed ID: 26547121
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Characterization of Irreversible Electroporation Ablation with a Validated Perfused Organ Model.
    Bhonsle S; Bonakdar M; Neal RE; Aardema C; Robertson JL; Howarth J; Kavnoudias H; Thomson KR; Goldberg SN; Davalos RV
    J Vasc Interv Radiol; 2016 Dec; 27(12):1913-1922.e2. PubMed ID: 27663353
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Magnetic anchoring and guidance-assisted endoscopic irreversible electroporation for gastric mucosal ablation: a preclinical study in canine model.
    Li Q; Gao X; Zhang Y; Han X; Li Z; Zhang Y; Wang Y; Liang L; Chu D; Wu Z; Wang B; Wu R; Lv Y; Ren F
    Surg Endosc; 2021 Oct; 35(10):5665-5674. PubMed ID: 33420599
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Combinatorial effect of radium-223 and irreversible electroporation on prostate cancer bone metastasis in mice.
    Rojo RD; Perez JVD; Damasco JA; Yu G; Lin SC; Heralde FM; Novone NM; Santos EB; Lin SH; Melancon MP
    Int J Hyperthermia; 2021; 38(1):650-662. PubMed ID: 33882773
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Irreversible electroporation: implications for prostate ablation.
    Onik G; Mikus P; Rubinsky B
    Technol Cancer Res Treat; 2007 Aug; 6(4):295-300. PubMed ID: 17668936
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Irreversible Electroporation for the Ablation of Renal Cell Carcinoma: A Prospective, Human, In Vivo Study Protocol (IDEAL Phase 2b).
    Buijs M; van Lienden KP; Wagstaff PG; Scheltema MJ; de Bruin DM; Zondervan PJ; van Delden OM; van Leeuwen TG; de la Rosette JJ; Laguna MP
    JMIR Res Protoc; 2017 Feb; 6(2):e21. PubMed ID: 28209559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. US findings after irreversible electroporation ablation: radiologic-pathologic correlation.
    Appelbaum L; Ben-David E; Sosna J; Nissenbaum Y; Goldberg SN
    Radiology; 2012 Jan; 262(1):117-25. PubMed ID: 22106355
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Irreversible electroporation: Beyond the limits of tumor ablation.
    Alonso-González R; Abadal Villayandre JM; Gálvez Gonzalez E; Álvarez Perez MJ; Méndez Alonso S; de Gregorio Ariza MA
    Radiologia (Engl Ed); 2024; 66(1):47-56. PubMed ID: 38365354
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.